<rst>
<header>
	<relations>
			<rel name="elaboration" type="rst"/>
			<rel name="background" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="purpose" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">1. Introduction</segment>
<segment id="2" parent="1004" relname="span">Rheumatoid arthritis</segment>
<segment id="3" parent="2" relname="elaboration">( RA )</segment>
<segment id="4" parent="1003" relname="same_unit">is an autoimmune condition ,</segment>
<segment id="5" parent="1005" relname="span">characterized by symmetrical joint inflammation ,</segment>
<segment id="6" parent="5" relname="elaboration">that affects approximately 1 % of the world ’s population .</segment>
<segment id="7" parent="1007" relname="preparation">RA is characterized mainly by synovium hyperplasia and a joint destruction process .</segment>
<segment id="8" parent="1008" relname="span">In this scenario , immune cells and the inflammatory microenvironment</segment>
<segment id="9" parent="8" relname="elaboration">that they create in affected joints are key components in the pathophysiology of RA .</segment>
<segment id="10" parent="1010" relname="span">Moreover , it is well-described that during the inflammatory stages of the disease , extra-articular manifestations are common ,</segment>
<segment id="11" parent="10" relname="elaboration">which involve other tissues or organs .</segment>
<segment id="12" parent="1012" relname="span">RA patients are at risk of systemic complications and several co-morbidities ,</segment>
<segment id="13" parent="12" relname="elaboration">including osteoporosis and frequent vertebral and hip fragility fractures .</segment>
<segment id="14" parent="1015" relname="sequence">The incidence rate of overall fractures in RA patients is 33 per 1000 person-years ,</segment>
<segment id="15" parent="1015" relname="sequence">and the risk is increased with disease activity</segment>
<segment id="16" parent="1017" relname="span">and associated with overexpression of pro-inflammatory cytokines</segment>
<segment id="17" parent="16" relname="elaboration">that can disturb the bone remodeling process .</segment>
<segment id="18" parent="1019" relname="span">Over the last decades , animal models — especially the rodent models — have been crucial tools</segment>
<segment id="19" parent="1020" relname="joint">for understanding the biologic process of RA ,</segment>
<segment id="20" parent="1020" relname="joint">and their use can aid in developing new therapeutic strategies for fracture healing in RA inflammatory conditions .</segment>
<segment id="21" parent="1023" relname="span">Collagen induced-arthritis</segment>
<segment id="22" parent="21" relname="restatement">( CIA )</segment>
<segment id="23" parent="1022" relname="same_unit">animal models have been one of the most widely used models in RA research .</segment>
<segment id="24" parent="1024" relname="span">Originally described by Trentham , CIA is a reproducible animal experimental model of RA .</segment>
<segment id="25" parent="1026" relname="span">In fact , the similarity to human RA</segment>
<segment id="26" parent="1027" relname="span">regarding the disease clinical , histological , and immunological signals</segment>
<segment id="27" parent="1028" relname="span">—</segment>
<segment id="28" parent="1029" relname="span">including high articular levels of inflammatory cytokines — like tumor necrosis factor-α</segment>
<segment id="29" parent="28" relname="elaboration">( TNF-α ) ,</segment>
<segment id="30" parent="1030" relname="span">make it an invaluable model</segment>
<segment id="31" parent="1031" relname="joint">to study the pathologic process</segment>
<segment id="32" parent="1031" relname="joint">and to search new therapeutic strategies .</segment>
<segment id="33" parent="1033" relname="span">The response to rat CIA has been reported to involve macrophages , T and B lymphocytes , and mediators such as TNF-α , Interleukin</segment>
<segment id="34" parent="33" relname="elaboration">( IL)-1β , IL-6 , and IL-17 .</segment>
<segment id="35" parent="1035" relname="span">Nonetheless , the systemic response in this model has not been well characterized so far .</segment>
<segment id="36" parent="1036" relname="joint">Importantly , current RA treatments do not promote joint repair ,</segment>
<segment id="37" parent="1038" relname="span">and several efforts are being made</segment>
<segment id="38" parent="37" relname="purpose">to develop new therapies ,</segment>
<segment id="39" parent="1039" relname="span">especially based in cell approaches</segment>
<segment id="40" parent="1040" relname="span">using mesenchymal stem/stromal cells</segment>
<segment id="41" parent="40" relname="elaboration">( MSC ) .</segment>
<segment id="42" parent="1043" relname="span">MSC are multipotent progenitor cells with the potential to differentiate into mesenchymal lineage tissues</segment>
<segment id="43" parent="42" relname="elaboration">( e. g. , bone , cartilage , and adipose tissue ) ,</segment>
<segment id="44" parent="1044" relname="joint">described to have immunomodulatory roles ,</segment>
<segment id="45" parent="1044" relname="joint">being capable of recruiting different cell types</segment>
<segment id="46" parent="1044" relname="joint">and promoting tissue repair .</segment>
<segment id="47" parent="1048" relname="span">The transplantation of MSC has been reported</segment>
<segment id="48" parent="47" relname="purpose">to ameliorate or delay RA onset in CIA animals ,</segment>
<segment id="49" parent="1049" relname="sequence">partially mediated by inflammatory signaling suppression ,</segment>
<segment id="50" parent="1049" relname="sequence">and thereby reducing joint swelling and destruction .</segment>
<segment id="51" parent="52" relname="concession">Although the available evidence supports the use of MSC transplantation as a cell-based strategy in CIA animals ,</segment>
<segment id="52" parent="1051" relname="span">data on the biology of endogenous CIA animals-derived MSC in basal conditions is scarce .</segment>
<segment id="53" parent="1009" relname="joint">Moreover , the impact of the systemic inflammatory condition on biological properties of endogenous MSC has not been explored yet .</segment>
<segment id="54" parent="1055" relname="span">Herein , we propose CIA as a reliable model</segment>
<segment id="55" parent="54" relname="purpose">to study bone regeneration in inflammatory conditions ,</segment>
<segment id="56" parent="1056" relname="span">and additionally we investigate the effect of RA induction on the biological behavior of endogenous MSC as crucial cells</segment>
<segment id="57" parent="56" relname="elaboration">involved in repair/regeneration .</segment>
<segment id="58" parent="1059" relname="attribution">Our results have shown</segment>
<segment id="59" parent="1059" relname="joint">that the combination of the two models is feasible</segment>
<segment id="60" parent="1061" relname="span">and that CIA animals respond to the bone injury with a significant increase of systemic myeloid cells number and their co-stimulatory molecules</segment>
<segment id="61" parent="60" relname="elaboration">( CD40 and CD86 )</segment>
<segment id="62" parent="1062" relname="span">expression ,</segment>
<segment id="63" parent="62" relname="elaboration">accompanied by increased levels of IL-13 , IL-2 , and IL-6 in plasma .</segment>
<segment id="64" parent="1064" relname="span">The systemic inflammatory environment</segment>
<segment id="65" parent="64" relname="elaboration">created by the arthritis induction leads to decreased metabolic activity and proliferation of CIA-derived MSC ,</segment>
<segment id="66" parent="1065" relname="span">and increased differentiation capacity</segment>
<segment id="67" parent="1066" relname="span">determined by the expression of osteogenic</segment>
<segment id="68" parent="1069" relname="span">( runt-related transcription factor 2</segment>
<segment id="69" parent="68" relname="elaboration">( RUNX2 ) and alkaline phosphatase</segment>
<segment id="70" parent="1069" relname="restatement">( ALP ) ) , and chondrogenic</segment>
<segment id="71" parent="1071" relname="span">( aggrecan</segment>
<segment id="72" parent="71" relname="restatement">( ACAN ) )</segment>
<segment id="73" parent="1070" relname="same_unit">markers in basal conditions .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1006" relname="background"/>
<group id="1003" type="multinuc" parent="1002" relname="span"/>
<group id="1004" type="span" parent="1003" relname="same_unit"/>
<group id="1005" type="span" parent="1003" relname="elaboration"/>
<group id="1006" type="span" parent="1001" relname="span"/>
<group id="1007" type="multinuc" parent="1006" relname="span"/>
<group id="1008" type="span" parent="1007" relname="sequence"/>
<group id="1009" type="multinuc" parent="1007" relname="sequence"/>
<group id="1010" type="span" parent="1009" relname="joint"/>
<group id="1012" type="span" parent="1009" relname="joint"/>
<group id="1014" type="span" parent="1009" relname="joint"/>
<group id="1015" type="multinuc" parent="1014" relname="span"/>
<group id="1017" type="span" parent="1015" relname="sequence"/>
<group id="1018" type="span" parent="1015" relname="elaboration"/>
<group id="1019" type="span" parent="1018" relname="span"/>
<group id="1020" type="multinuc" parent="18" relname="purpose"/>
<group id="1021" type="span" parent="1019" relname="elaboration"/>
<group id="1022" type="multinuc" parent="1021" relname="span"/>
<group id="1023" type="span" parent="1022" relname="same_unit"/>
<group id="1024" type="span" parent="1022" relname="elaboration"/>
<group id="1025" type="multinuc" parent="24" relname="elaboration"/>
<group id="1026" type="span" parent="1025" relname="same_unit"/>
<group id="1027" type="span" parent="25" relname="elaboration"/>
<group id="1028" type="span" parent="26" relname="elaboration"/>
<group id="1029" type="span" parent="27" relname="elaboration"/>
<group id="1030" type="span" parent="1025" relname="same_unit"/>
<group id="1031" type="multinuc" parent="30" relname="purpose"/>
<group id="1033" type="span" parent="1009" relname="joint"/>
<group id="1035" type="span" parent="1009" relname="joint"/>
<group id="1036" type="multinuc" parent="35" relname="elaboration"/>
<group id="1037" type="multinuc" parent="1036" relname="joint"/>
<group id="1038" type="span" parent="1037" relname="same_unit"/>
<group id="1039" type="span" parent="1037" relname="same_unit"/>
<group id="1040" type="span" parent="39" relname="means"/>
<group id="1042" type="multinuc" parent="1009" relname="joint"/>
<group id="1043" type="span" parent="1042" relname="same_unit"/>
<group id="1044" type="multinuc" parent="1042" relname="same_unit"/>
<group id="1047" type="multinuc" parent="1009" relname="joint"/>
<group id="1048" type="span" parent="1047" relname="same_unit"/>
<group id="1049" type="multinuc" parent="1047" relname="same_unit"/>
<group id="1051" type="span" parent="1009" relname="joint"/>
<group id="1054" type="multinuc" parent="1009" relname="joint"/>
<group id="1055" type="span" parent="1054" relname="same_unit"/>
<group id="1056" type="span" parent="1054" relname="same_unit"/>
<group id="1057" type="span" parent="1009" relname="joint"/>
<group id="1058" type="span" parent="1057" relname="span"/>
<group id="1059" type="multinuc" parent="1058" relname="span"/>
<group id="1060" type="multinuc" parent="1059" relname="joint"/>
<group id="1061" type="span" parent="1060" relname="same_unit"/>
<group id="1062" type="span" parent="1060" relname="same_unit"/>
<group id="1063" type="multinuc" parent="1058" relname="elaboration"/>
<group id="1064" type="span" parent="1063" relname="joint"/>
<group id="1065" type="span" parent="1063" relname="joint"/>
<group id="1066" type="span" parent="66" relname="elaboration"/>
<group id="1067" type="span" parent="67" relname="elaboration"/>
<group id="1068" type="span" parent="1067" relname="span"/>
<group id="1069" type="span" parent="1068" relname="span"/>
<group id="1070" type="multinuc" parent="1068" relname="elaboration"/>
<group id="1071" type="span" parent="1070" relname="same_unit"/>
	</body>
</rst>
